Genetic knockout of Shoc2 suppresses the growth of a subset of KRAS-mutant cancer cell lines and inhibits tumour growth in mouse models of KRAS-driven lung cancer28–30, demonstrating that SHOC2 function is critical for RAS–RAF pathway activation. The gene discussed is KRAS; the disease is neoplasm.